Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD33 (clone IT-YF0Z5L3). We employs the pGEX (CMV-TurboGFP-IL-10-SaII) vector components and the SynExpress system of the Exons Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD33
Clone
IT-YF0Z5L3
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
TurboGFP
Promoter
CMV
Effector Gene
IL-10
Insertion Sites
SaII
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
pGEX
Transformation Accuracy
0.98
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.